Association between Acquired Rifamycin Resistance and the Pharmacokinetics of Rifabutin and Isoniazid among Patients with HIV and Tuberculosis
Marc Weiner(The University of Texas at San Antonio Health Science Center), Thomas Hodge(Centers for Disease Control and Prevention), Charles A. Peloquin(University of Florida), Andrew Vernon(Centers for Disease Control and Prevention), Abdul Qadir Khan(Centers for Disease Control and Prevention), Debra Benator(George Washington University), Brenda Jones(University of Southern California), Zhen Zhao(Cornell University), W. J. Burman(University of Colorado Health), Claudia Silva‐Trigo(University of Southern California)
Cited by 227
Related Papers
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
|Clinical Infectious Diseases|2016|1.5k
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
|PubMed|2010|1.1k
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
|PsycEXTRA Dataset|2005|694
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
|New England Journal of Medicine|2021|548
Hidden Little Monsters: Spectroscopic Identification of Low-mass, Broad-line AGNs at z > 5 with CEERS
|The Astrophysical Journal Letters|2023|381